Sphingosine Kinase: A Novel Putative Target for the Prevention of Infection-Triggered Preterm Birth
Preterm birth is defined as any delivery before 37 complete weeks of gestation. It is a universal challenge in the field of obstetrics owing to its high rate of mortality, long-term morbidity, associated human suffering and economic burden. In the United States, about 12.18% deliveries in 2009 were...
Saved in:
Main Authors: | Vibhuti Vyas (Author), Charles R. Ashby (Author), Sandra E. Reznik (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sphingosine kinase 1 as an anticancer therapeutic target
by: Gao Y, et al.
Published: (2015) -
Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
by: Alessandro Cannavo, et al.
Published: (2017) -
Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
by: Faez Iqbal Khan, et al.
Published: (2020) -
Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1
by: Sonam Roy, et al.
Published: (2020) -
The Matrix Metalloproteases and Endothelin-1 in Infection-Associated Preterm Birth
by: Nicole S. Olgun, et al.
Published: (2010)